Suppr超能文献

糖尿病对印度尼西亚日惹市耐多药结核病发展的影响。

Influence of Diabetes Mellitus on the Development of Multi Drug Resistant-Tuberculosis in Yogyakarta.

作者信息

Saktiawati Antonia Morita Iswari, Subronto Yanri Wijayanti

机构信息

Department of Internal Medicine, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta.

出版信息

Acta Med Indones. 2018 Jan;50(1):11-17.

Abstract

BACKGROUND

the correlation between diabetes mellitus (DM) and Multi-Drug-Resistant Tuberculosis (MDR-TB) has never been studied among patients with tuberculosis (TB) in Indonesia, while DM has been identified to alter immune response and pharmacokinetics of TB medications that may lead to a failure of TB treatment and develop MDR-TB. Our study aimed to analyze the influence of diabetes mellitus on the development of MDR-TB.

METHODS

a retrospective cohort study was carried out on 356 TB patients at the Provincial Lung Clinics and Sardjito Hospital, Yogyakarta, Indonesia between 2010 and 2014. Diagnosis of MDR-TB was established based on GeneXpert or drug sensitivity testing, while DM was determined based on the criteria in the National Guidelines. Demographic, epidemiological and outcome variables were collected. Odds ratios and 95% confidence intervals (95% CI) were analyzed using simple logistic regression.

RESULTS

among 356 TB patients, 23 patients were with binomial TB-DM, while 333 patients did not suffered from DM. Patients with TB-DM presented a 6.8-fold (95% CI:2.0-23.7, p=0.003) higher risk of developing MDR-TB. Individuals with TB-DM had a 4.4-fold (95% CI:1.5-12.9, p=0.008) greater chance to have positive sputum smear by the second month of treatment indicating a delay in the resolution of the tuberculosis infection.

CONCLUSION

there was a significant correlation between diabetes mellitus and MDR-TB development. Therefore, it is suggested that clinicians at all levels of health care service should conduct any kind of screening test for MDR-TB in such group of patients. Further prospective cohort study is needed to confirm the findings of this preliminary study.

摘要

背景

在印度尼西亚的结核病患者中,从未研究过糖尿病(DM)与耐多药结核病(MDR-TB)之间的相关性,而糖尿病已被证实会改变免疫反应和抗结核药物的药代动力学,这可能导致结核病治疗失败并发展为耐多药结核病。我们的研究旨在分析糖尿病对耐多药结核病发展的影响。

方法

对2010年至2014年期间在印度尼西亚日惹省肺病诊所和萨迪托医院的356例结核病患者进行了一项回顾性队列研究。耐多药结核病的诊断基于GeneXpert或药敏试验,而糖尿病则根据国家指南中的标准确定。收集了人口统计学、流行病学和结局变量。使用简单逻辑回归分析比值比和95%置信区间(95%CI)。

结果

在356例结核病患者中,23例患有双项结核病-糖尿病,而333例患者未患糖尿病。结核病-糖尿病患者发生耐多药结核病的风险高6.8倍(95%CI:2.0-23.7,p=0.003)。结核病-糖尿病患者在治疗第二个月时痰涂片阳性的可能性高4.4倍(95%CI:1.5-12.9,p=0.008),表明结核感染的消退延迟。

结论

糖尿病与耐多药结核病的发展之间存在显著相关性。因此,建议各级医疗保健服务机构的临床医生对这类患者进行任何类型的耐多药结核病筛查试验。需要进一步的前瞻性队列研究来证实这项初步研究的结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验